Risk factors associated with unfavorable short-term treatment outcome in patients with documented Pseudomonas aeruginosa infection.

about

Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study

P2860

Q33867208-41B78319-7045-4CBA-B072-D92FB24E2670

P2860

Risk factors associated with unfavorable short-term treatment outcome in patients with documented Pseudomonas aeruginosa infection.

Item

http://www.wikidata.org/entity/Q41512238

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Risk factors associated with u ...... udomonas aeruginosa infection.

@en

type

Item

label

Risk factors associated with u ...... udomonas aeruginosa infection.

@en

prefLabel

Risk factors associated with u ...... udomonas aeruginosa infection.

@en

P1476

Risk factors associated with u ...... udomonas aeruginosa infection.

@en

P2093

Mary L Townsend

http://www.w3.org/2001/XMLSchema#string

Richard H Drew

http://www.w3.org/2001/XMLSchema#string

V Paul DiMondi

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment

The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression.

Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance

Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes.

Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.

Prescribing guidelines for severe Pseudomonas infections.

P2888

s11096-015-0067-6

P304

348-354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11096-015-0067-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25637406

http://www.w3.org/2001/XMLSchema#string

Risk factors associated with unfavorable short-term treatment outcome in patients with documented Pseudomonas aeruginosa infection.

about

P2860

P2860

Risk factors associated with unfavorable short-term treatment outcome in patients with documented Pseudomonas aeruginosa infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698